Cite

HARVARD Citation

    MaruYama, T. et al. (2021). Curcumin analog GO‐Y030 boosts the efficacy of anti‐PD‐1 cancer immunotherapy. Cancer science. 112 (12), pp. 4844-4852. [Online]. 
  
Back to record